Main Street Financial Solutions’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Main Street Financial Solutions's IBB Position: Q4 2025 in Review
Main Street Financial Solutions increased its iShares Biotechnology ETF (IBB) stake by 49% in Q4 2025, buying an estimated $688K and bringing the position to 12,932 shares worth $2.18M. The position accounts for 0.16% of the portfolio, ranked #127.
Main Street Financial Solutions first reported a position in IBB in Q4 2020 and has held it in 21 quarters since. 955 funds tracked by Wall St. Rank hold IBB as of Q4 2025.
- Main Street Financial Solutions held 12,932 shares of iShares Biotechnology ETF worth $2.18M as of Q4 2025.
- Main Street Financial Solutions bought 4,238 iShares Biotechnology ETF shares in Q4 2025, an estimated $688K.
- iShares Biotechnology ETF made up 0.16% of Main Street Financial Solutions's portfolio in Q4 2025, its #127 holding.
- Main Street Financial Solutions first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 21 quarters since.
- 955 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.
Based on Main Street Financial Solutions's 13F filing for Q4 2025, filed 17 Feb 2026.